Get In Touch
Follow on LinkedIn
Joel is an Operating Partner with an expertise in healthcare technology and population health. Joel is the Chairman of IBH and serves on the Board of WPAS.
Joel is currently the CEO of Egnite Health and is the former CEO of KEPRO.
Before joining KEPRO, Joel was the CEO of Intermedix. Under his leadership, Intermedix grew adjacently from its core business to become a leading healthcare analytics and tech-enabled services company. In May 2018, Joel led Intermedix’s acquisition to R1 RCM (NASDAQ:RCM) in a $460 million cash transaction.
Joel was awarded Most Admired CEO by the Nashville Business Journal in 2017 and 2019. In 2013, he received the Alumni Achievement Award for Professional Achievement from the University of South Dakota, and, in 2012, was named Trustee Emeritus by Hamline University. His vision and expertise helped land his previous company, Intermedix, on Forbes Magazine’s “2018 America’s Best Midsize Employers List” and “2018 America’s Best Employer for Women”.
Earlier in his career, he co-founded two start-up companies that were acquired by market-leading corporations (UnitedHealth Group (NYSE:UNH) and LexisNexis). Joel also served as the president of Verisk Health, where he drove the integration and explosive growth of the healthcare assets of Verisk Analytics (NYSE:VRSK) over a five-year period, prior to its acquisition by Veritas Capital.
Through the course of his career he has done business in twenty-nine countries with offices on four continents and navigated in fast-paced entrepreneurial settings, publicly traded companies, and private equity.
Joel received a bachelor of science from the University of South Dakota and a master of arts from Hamline University. He currently serves on the board of directors for Apixio, Inc. and KEPRO, as well as the Board of Directors for the USD Foundation. He proudly served as a member of the Air National Guard for ten years.